Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,161
Active & Responsive
FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors
for
Solid Tumor
Location: New Haven CT, Charleston SC, Denver CO, Portland OR
FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions
for
Acute Ischemic Stroke,
Location: New Haven CT, Stony Brook NY, Manhasset NY, York PA,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT07749170
Recruiting
Active & Responsive
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
for
NAFLD
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 12 - 18
Code: NCT04634643
Recruiting
Active & Responsive
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigoâ„¢ Aspiration System (STRIDE II)
for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: New Haven CT, New York NY, Worcester MA, Lebanon NH,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT06747117
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Speech Motor Learning and Retention (Aim 3)
for
Speech
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 40
Code: NCT06492252
Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for
Solid Tumor
Location: New Haven CT, The Bronx NY, Boston MA, Philadelphia PA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06619587
Phase 1, Recruiting
Active & Responsive
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
Location: New Haven CT, Lake Success NY, New York NY, Fairfax VA,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07361562
Phase 1, Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for
Metastatic Colorectal Cancer
Location: New Haven CT, Port Jefferson Station NY, The Bronx NY,
Location: New Haven CT, Lake Success NY, New York NY, Boston MA,
Sponsor: Pheast Therapeutics
Sex: All
Age: 18+
Code: NCT06840886
Phase 1, Recruiting
Active & Responsive
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07101328
Phase 1, Recruiting
Active & Responsive
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
for
Primary Immune Thrombocytopenia (ITP),
Location: New Haven CT, Stamford CT, The Bronx NY, Summit NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07421167
Phase 2, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Location: New Haven CT, The Bronx NY, Lake Success NY,
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase 2, Recruiting
Active & Responsive
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
for
Head and Neck Cancer Squamous Cell Carcinoma
Location: New Haven CT, Manhattan NY
Sponsor: VSPharmTech Co.,Ltd.
Sex: All
Age: 18+
Code: NCT06959082
Phase 2, Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours